When Tom De Caluwé and Maurice Van Kerkhoven decided in 2009 – over a glass of good Amarone wine under the Italian sun – to set up their own company, they were well aware of how much work still needed to be done in the field of healthcare interoperability.
Initially, Amaron focussed on HL7 interfaces between the various information systems used within the hospital. But driven by healthcare’s growing needs, we evolved our portfolio towards broader interoperability, with solutions that enable hospitals to exchange data externally, with other healthcare providers, as well.
And as governments strive to improve healthcare efficiency by centralising more and more data in national and regional e-health platforms, healthcare providers can rely on Amaron to enable the automatic transfer of this data.
Over the years, we noticed that certain things were still slipping through the cracks. To fill those gaps, we developed Workflower: a platform that allows you to automate all kinds of processes, and to collaborate better across domains, disciplines and disparate IT systems.
In early 2021, two investors came on board: HERAN Partners and Active Capital. Annie Vereecken from HERAN Partners and Jan Heyse from Active Capital are now members of Amaron’s board of directors, where they will help drive our further growth strategy and the internationalisation of our company.